The National Association of Pharmacy Regulatory Authorities (NAPRA) classified Neffy as a Schedule II product across Canada, ...

Allergy specialists submit an application to have a treatment approved for use in Guernsey.

A prospective, multicenter, noninterventional study conducted across Thailand, Taiwan, Malaysia, and Hong Kong has ...

Research highlights the role of nasal health in childhood ear infections, making nasal hygiene as important as oral ...

NPPA exempts Biodeal Pharma's antiepileptic nasal spray from DPCO price control for five years: Gireesh Babu, New Delhi Tuesday, November 10, 2026, 08:00 Hrs [IST] The National Ph ...

Canadians with severe allergies will now have greater access to what experts have called a game-changing treatment that ...

If you have frequent sinus symptoms that follow a seasonal pattern, allergies may be the root cause. Seasonal allergies can ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that its Board of ...

Welcome to What's Up Docs?, the podcast where doctors and identical twins Chris and Xand van Tulleken explore the ideas ...

Compass Pathways (NASDAQ:CMPS) could secure US regulatory approval for its experimental depression treatment COMP360 as early ...

On November 6, 2026, during the ninth China International Import Expo (CIIE) in Shanghai, BD, a global American medical ...

Pharmacist reveals six surprising signs of the infection, including one you might mistake for a dental problem ...